scispace - formally typeset
Open AccessJournal ArticleDOI

Biochemistry of arsenic detoxification

Barry P. Rosen
- 02 Oct 2002 - 
- Vol. 529, Iss: 1, pp 86-92
TLDR
While the overall schemes for arsenic resistance are similar in prokaryotes and eukaryotes, some of the specific proteins are the products of separate evolutionary pathways.
About
This article is published in FEBS Letters.The article was published on 2002-10-02 and is currently open access. It has received 726 citations till now. The article focuses on the topics: Arsenate reductase activity & Arsenate reductase.

read more

Citations
More filters
Journal ArticleDOI

The Ecology of Arsenic

TL;DR: This work reviews what is known about arsenic-metabolizing bacteria and their potential impact on speciation and mobilization of arsenic in nature and investigates their role in aquifers.
Journal ArticleDOI

Wound healing - A literature review.

TL;DR: The purpose of this review is to describe the various cellular and molecular aspects involved in the skin healing process.
Journal ArticleDOI

Arsenic hazards: strategies for tolerance and remediation by plants

TL;DR: Recent advances in arsenic tolerance are discussed and their potential applications, particularly in the context of multigenic engineering approaches, are discussed.
Journal ArticleDOI

Arsenic binding to proteins.

TL;DR: Although the adverse health effects arising from exposure to arsenic have been well-recognized, the mechanism(s) of action responsible for the diverse range of health effects are complicated and poorly understood.
Journal ArticleDOI

Occurrence of arsenic contamination in Canada: sources, behavior and distribution.

TL;DR: An analysis of the currently available information on recognized problem areas, and an overview of current knowledge of the principal hydrogeochemical processes of arsenic transportation and transformation are provided, however, a more detailed understanding of local sources of arsenic and mechanisms of arsenic release is required.
References
More filters
Journal Article

Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.

TL;DR: Transfecting two different eukaryotic expression vectors containing MRP complementary DNA into HeLa cells to study the pharmacological phenotype produced exclusively by overexpression of human MRP indicates that drug-resistant cell lines generated by transfection with MRp complementary DNA display some but not all of the characteristics of MRP-overexpressing cell lines produced by drug selection in vitro.
Journal ArticleDOI

Cellular and molecular biology of the aquaporin water channels.

TL;DR: The high water permeability characteristic of mammalian red cell membranes is now known to be caused by the protein AQP1, a tetramer with each subunit containing an aqueous pore likened to an hourglass formed by obversely arranged tandem repeats.
Journal ArticleDOI

Microbial arsenic: from geocycles to genes and enzymes.

TL;DR: The DNA sequencing and protein crystal structures have established the convergent evolution of three classes of arsenate reductases, which involve three cysteine thiols and S-As bond intermediates, so convergence evolution to similar mechanisms has taken place.
Journal ArticleDOI

Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein

TL;DR: It is demonstrated that depletion of intracellular glutathione by DL-buthionine (S,R)-sulfoximine results in a complete reversal of resistance to doxorubicin, daunorubICin, vincristine, and VP-16 in lung carcinoma cells transfected with a MRP cDNA expression vector, and this results support the hypothesis that MRP functions as a glutATHione S-conjugate carrier.
Journal ArticleDOI

Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9

TL;DR: The results suggest that AQP9 and AQP7 may be a major routes of arsenite uptake into mammalian cells, an observation potentially of large importance for understanding the action of arsenic as a human toxin and carcinogen, as well as its efficacy as a chemotherapeutic agent for acute promyelocytic leukemia.
Related Papers (5)